Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shilpen A. Patel"'
Autor:
Perrin E. Romine, Renato G. Martins, Keith D. Eaton, Douglas E. Wood, Fatemeh Behnia, Bernardo H. L. Goulart, Michael S. Mulligan, Sarah G. Wallace, Elizabeth Kell, Julie E. Bauman, Shilpen A. Patel, Hubert J. Vesselle
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Neoadjuvant chemotherapy is effective in improving survival of resectable NSCLC. Based on findings in the adjuvant and metastatic setting, FDG positron emission tomography (PET) scans may offer early prognostic or predictive value
Externí odkaz:
https://doaj.org/article/0b333ebbba4a47c1b41710fc169460fd
Autor:
Laura K. McNew, MD, Stephen R. Bowen, PhD, Olga Gopan, PhD, Matthew J. Nyflot, PhD, Shilpen A. Patel, MD, Jing Zeng, MD, Ramesh Rengan, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 2, Pp 192-196 (2017)
Purpose: The results from Radiation Therapy Oncology Group (RTOG) 0617, a dose escalation trial that compared treatment with 60 Gy versus 74 Gy for patients with stage III non-small cell lung cancer (NSCLC), suggested that in these patients, the hear
Externí odkaz:
https://doaj.org/article/5ded62fa15e64eb6a3fdf0b8848ceabb
Autor:
Lia M Halasz, Shilpen A Patel, Jean A McDougall, Catherine Fedorenko, Qin Sun, Bernardo H L Goulart, Joshua A Roth
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222904 (2019)
PURPOSE:In 2013, the American Society for Radiation Oncology (ASTRO) issued a Choosing Wisely recommendation against the routine use of intensity modulated radiotherapy (IMRT) for whole breast irradiation. We evaluated IMRT use and subsequent impact
Externí odkaz:
https://doaj.org/article/38524622e5a64c2d93d52782688a6296
Publikováno v:
Journal of Clinical Oncology. 40:84-84
84 Background: Only 2-8% of adult patients with cancer participate in clinical trials, likely due to strict exclusion criteria as well as financial and access issues. The primary objective of this study is to understand the population of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b23be8b0107d433728081de4ffb2d88b
https://doi.org/10.1200/jco.2022.40.28_suppl.084
https://doi.org/10.1200/jco.2022.40.28_suppl.084
Autor:
Nicole E. Caston, Fallon Lalor, Jaclyn Wall, Jesse Sussell, Shilpen A. Patel, Courtney Williams, Andres Azuero, Rebecca Christian Arend, Margaret Irene Liang, Gabrielle Betty Rocque
Publikováno v:
Journal of Clinical Oncology. 40:85-85
85 Background: Most patients with cancer experience multi-leveled barriers to clinical trial participation, potentially including financial concerns due to the complexity surrounding trial-related insurance coverage. Our study sought to understand th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec34621206f371d4180d7f343783da8d
https://doi.org/10.1200/jco.2022.40.28_suppl.085
https://doi.org/10.1200/jco.2022.40.28_suppl.085
Autor:
Stephen R Bowen, Matthew J Nyflot, Michael Gensheimer, Kristi R G Hendrickson, Paul E Kinahan, George A Sandison, Shilpen A Patel
Publikováno v:
Clinical and Translational Medicine, Vol 1, Iss 1, Pp n/a-n/a (2012)
Abstract The increasing interest in combined positron emission tomography (PET) and computed tomography (CT) to guide lung cancer radiation therapy planning has been well documented. Motion management strategies during treatment simulation PET/CT ima
Externí odkaz:
https://doaj.org/article/c3a1e07da8c84b5b83473924e8d6f578